SUNPHARMA is breaking down from its long-term channel. It consolidated in the form of a triangle and is now seemingly breaking down from the base of the triangle. The 200DMA is also being rejected. A fall to 735 zone is possible on the stock.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.